Nearly half of all women experience some sort of sexual dysfunction. Clinicians should be comfortable speaking with patients about their sexual health.
The reproductive hormone kisspeptin may offer a much needed treatment for hypoactive sexual desire disorder in men and women, results from two small studies suggest.
Researchers review the existing trials for flibanserin (Addyi), or "female Viagra," and the very modest benefits of the drug do not outweigh the harms.